AlphaFold predicted structure
IMPDH1 · P20839

Mean pLDDT
92.7/ 100
Very high
514 residues
Confidence breakdown
- Very high(≥ 90)79%
- Confident(70–90)18%
- Low(50–70)2%
- Very low(< 50)0%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
inosine monophosphate dehydrogenase 1
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Retinal disorders
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownGlaucoma (developmental)
Ophthalmological ciliopathies
Primary ciliary disorders
Rare multisystem ciliopathy disorders
Skeletal dysplasia
Structural eye disease
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedThoracic dystrophies
retinitis pigmentosa
retinitis pigmentosa 10
Leber congenital amaurosis
chronic hepatitis C virus infection
hepatitis C virus infection
Leber congenital amaurosis 11
cirrhosis of liver
acute lymphoblastic leukemia
viral infectious disease
Crohn disease
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Inosine-5'-monophosphate dehydrogenase 1
Catalyzes the conversion of inosine 5'-phosphate (IMP) to xanthosine 5'-phosphate (XMP), the first committed and rate-limiting step in the de novo synthesis of guanine nucleotides, and therefore plays an important role in the regulation of cell growth. Could also have a single-stranded nucleic acid-binding activity and could play a role in RNA and/or DNA metabolism. It may also have a role in the development of malignancy and the growth progression of some tumors
IMPDH1 · P20839

Mean pLDDT
92.7/ 100
Very high
514 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0